Drug recall · October 16, 2019
Sodium Chloride Injection USP 0.9% recall
Why: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Sodium Chloride Injection USP 0.9%, packaged in 1 - 125 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1188-27.
- Lots / codes
Lots: L159A, Exp. 06/2021; L169A, Exp. 07/2021
- Quantity
- 3140 syringes
- Company
- Guerbet LLC, Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- September 13, 2019 · Voluntary: Firm initiated
- Classified
- October 9, 2019
- Reported
- October 16, 2019
- Ended
- October 25, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.